Because no genetic alternation that is heavily implicated in the upregulation of HLA-G gene, such as copy number gain or translocation, is detected in cancer genome, elevated HLA-G promoter activity is thought to be crucial for its expression in tumors. This evidence concerns the gene HLA-G and cancer.